| Lipid nanoparticles as delivery systems for RNA-based vaccines BN Aldosari, IM Alfagih, AS Almurshedi Pharmaceutics 13 (2), 206, 2021 | 194 | 2021 |
| Nanoparticles as adjuvants and nanodelivery systems for mRNA-based vaccines IM Alfagih, B Aldosari, B AlQuadeib, A Almurshedi, MM Alfagih Pharmaceutics 13 (1), 45, 2020 | 70 | 2020 |
| Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components NS Barakat, IM Elbagory, AS Almurshedi Drug delivery 16 (1), 57-65, 2009 | 65 | 2009 |
| Zinc Oxide Nanoparticles as Potential Delivery Carrier: Green Synthesis by Aspergillus niger Endophytic Fungus, Characterization, and In Vitro/In Vivo Antibacterial … DH Abdelkader, WA Negm, E Elekhnawy, D Eliwa, BN Aldosari, ... Pharmaceuticals 15 (9), 1057, 2022 | 63 | 2022 |
| A novel pH-sensitive liposome to trigger delivery of afatinib to cancer cells: Impact on lung cancer therapy AS Almurshedi, M Radwan, S Omar, AA Alaiya, MM Badran, H Elsaghire, ... Journal of Molecular Liquids 259, 154-166, 2018 | 49 | 2018 |
| Controlled-release carbamazepine granules and tablets comprising lipophilic and hydrophilic matrix components NS Barakat, IM Elbagory, AS Almurshedi aaps Pharmscitech 9, 1054-1062, 2008 | 41 | 2008 |
| Formulation, release characteristics and bioavailability study of oral monolithic matrix tablets containing carbamazepine NS Barakat, IM Elbagory, AS Almurshedi AAPS PharmSciTech 9 (3), 931-938, 2008 | 41 | 2008 |
| Intranasal delivery of chitosan decorated nanostructured lipid carriers of Buspirone for brain targeting: Formulation development, optimization and In-Vivo preclinical evaluation KM Noorulla, M Yasir, F Muzaffar, S Roshan, MM Ghoneim, ... Journal of Drug Delivery Science and Technology 67, 102939, 2022 | 36 | 2022 |
| Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation NS Barakat, AS Almurshedi Journal of Pharmacy and Pharmacology 63 (2), 169-178, 2011 | 30 | 2011 |
| A novel sustained anti-inflammatory effect of atorvastatin—calcium PLGA nanoparticles: in vitro optimization and in vivo evaluation DH Abdelkader, AK Abosalha, MA Khattab, BN Aldosari, AS Almurshedi Pharmaceutics 13 (10), 1658, 2021 | 29 | 2021 |
| Development of inhalable nanostructured lipid carriers for ciprofloxacin for noncystic fibrosis bronchiectasis treatment AS Almurshedi, HA Aljunaidel, B Alquadeib, BN Aldosari, IM Alfagih, ... International Journal of Nanomedicine, 2405-2417, 2021 | 26 | 2021 |
| Wound healing efficacy of rosuvastatin transethosomal gel, I optimal optimization, histological and in vivo evaluation RM Zaki, VD Seshadri, AS Mutayran, LA Elsawaf, AM Hamad, ... Pharmaceutics 14 (11), 2521, 2022 | 23 | 2022 |
| Development and evaluation of luteolin loaded pegylated bilosome: optimization, in vitro characterization, and cytotoxicity study A Zafar, NK Alruwaili, SS Imam, OA Alsaidan, M Yasir, MM Ghoneim, ... Drug Delivery 28 (1), 2562-2573, 2021 | 19 | 2021 |
| Central composite optimization of glycerosomes for the enhanced oral bioavailability and brain delivery of quetiapine fumarate RM Zaki, MM Alfadhel, MA Alossaimi, LA Elsawaf, ... Pharmaceuticals 15 (8), 940, 2022 | 18 | 2022 |
| Fabrication and characterization of orodispersible films loaded with solid dispersion to enhance Rosuvastatin calcium bioavailability RM Zaki, M Alfadhel, VDD Seshadri, F Albagami, M Alrobaian, SM Tawati, ... Saudi Pharmaceutical Journal 31 (1), 135-146, 2023 | 15 | 2023 |
| Synthesis and characterization of antibiotic–loaded biodegradable citrate functionalized mesoporous hydroxyapatite nanocarriers as an alternative treatment for bone infections NH Alotaibi, MU Munir, NK Alruwaili, KS Alharbi, A Ihsan, AS Almurshedi, ... Pharmaceutics 14 (5), 975, 2022 | 13 | 2022 |
| Formulation of Gelucire®-Based Solid Dispersions of Atorvastatin Calcium: In Vitro Dissolution and In Vivo Bioavailability Study BN Aldosari, AS Almurshedi, IM Alfagih, BT AlQuadeib, MA Altamimi, ... AAPS PharmSciTech 22 (5), 161, 2021 | 13 | 2021 |
| Preparation and characterization of chitosan microparticles for oral sustained delivery of gliclazide: in vitro/in vivo evaluation NS Barakat, AS Almurshedi Drug Development Research 72 (3), 235-246, 2011 | 13 | 2011 |
| Utility of KRAS gene and clinicopathological features in the assessment of the risk of type 2 diabetes in the etiology of colon cancer WS Al-Qahtani, E Al-Olayan, FG Albani, RS Suliman, NH Aljarba, ... Global Medical Genetics 7 (02), 035-040, 2020 | 12 | 2020 |
| New investigation of anti-inflammatory activity of Polycladia crinita and biosynthesized selenium nanoparticles: isolation and characterization AS Almurshedi, TA El-Masry, H Selim, MM El-Sheekh, MEM Makhlof, ... Microbial Cell Factories 22 (1), 173, 2023 | 11 | 2023 |
